SpyGlass Pharma, Inc. (SGP)
24.00
-0.72
(-2.91%)
USD |
NASDAQ |
Oct 16, 16:00
24.16
+0.16
(+0.67%)
After-Hours: 20:00
SpyGlass Pharma Price to Book Value : 3.454 for Oct. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 3.454 |
| October 15, 2026 | 3.558 |
| October 14, 2026 | 3.410 |
| October 13, 2026 | 3.443 |
| October 12, 2026 | 3.578 |
| October 09, 2026 | 3.587 |
| October 08, 2026 | 3.544 |
| October 07, 2026 | 3.440 |
| October 06, 2026 | 3.567 |
| October 05, 2026 | 3.683 |
| October 02, 2026 | 3.587 |
| October 01, 2026 | 3.814 |
| September 30, 2026 | 3.742 |
| September 29, 2026 | 3.662 |
| September 28, 2026 | 3.740 |
| September 25, 2026 | 3.896 |
| September 24, 2026 | 3.980 |
| September 23, 2026 | 4.053 |
| September 22, 2026 | 4.130 |
| September 21, 2026 | 4.024 |
| September 18, 2026 | 4.186 |
| September 17, 2026 | 4.222 |
| September 16, 2026 | 4.117 |
| September 15, 2026 | 4.168 |
| September 14, 2026 | 4.125 |
| Date | Value |
|---|---|
| September 11, 2026 | 3.961 |
| September 10, 2026 | 3.931 |
| September 09, 2026 | 3.958 |
| September 08, 2026 | 4.163 |
| September 04, 2026 | 4.166 |
| September 03, 2026 | 4.173 |
| September 02, 2026 | 4.071 |
| September 01, 2026 | 3.866 |
| August 31, 2026 | 3.757 |
| August 28, 2026 | 3.803 |
| August 27, 2026 | 3.876 |
| August 26, 2026 | 3.834 |
| August 25, 2026 | 3.829 |
| August 24, 2026 | 3.780 |
| August 21, 2026 | 3.816 |
| August 20, 2026 | 3.776 |
| August 19, 2026 | 3.920 |
| August 18, 2026 | 3.719 |
| August 17, 2026 | 3.711 |
| August 14, 2026 | 3.771 |
| August 13, 2026 | 3.623 |
| August 12, 2026 | 3.637 |
| August 11, 2026 | 3.577 |
| August 10, 2026 | 3.622 |
| August 07, 2026 | 3.643 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.781 |
| Corcept Therapeutics, Inc. | 16.84 |
| Veru, Inc. | 1.382 |
| Johnson & Johnson | 7.243 |
| Eli Lilly & Co. | 34.93 |
Price to Book Value Related Metrics
| Price | 24.00 |
| Earnings Yield | -8.01% |
| Market Cap | 802.71M |